The Discounted Cash Flow (DCF) valuation of Neurocrine Biosciences Inc (NBIX) is 53.85 USD. With the latest stock price at 146.80 USD, the upside of Neurocrine Biosciences Inc based on DCF is -63.3%.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 8.7% | 7.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 35.05 - 133.85 | 53.85 |
| Upside | -76.1% - -8.8% | -63.3% |